Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -5.74% | +2.68% | -67.88% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 59.17M | Sales 2025 * | 88.09M | Capitalization | 29.88M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
6.76
x | Employees | 176 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1 day | -5.74% | ||
1 week | +2.68% | ||
Current month | -36.29% | ||
1 month | -23.08% | ||
3 months | -70.70% | ||
6 months | -30.93% | ||
Current year | -67.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.3 | -5.74% | 27,765 |
24-04-24 | 2.44 | -2.79% | 9,123 |
24-04-23 | 2.51 | +3.29% | 13,047 |
24-04-22 | 2.43 | +8.00% | 13,103 |
24-04-19 | 2.25 | +0.45% | 10,089 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.88% | 31.69M | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- CASI Stock